Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623

The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis

Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164

Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972

The “Primary” Antiphospholipid Syndrome

Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963

The "primary" antiphospholipid syndrome: major clinical and serological features.

Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718

Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers

Chaturvedi, S., & McCrae, K. R. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0668-2 · Cited by 17

Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's

Arnaud, L., Conti, F., Massaro, L., Denas, G., Chasset, F., & Pengo, V. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.09.003 · Cited by 16

Thromboprophylaxis and obstetric management of the antiphospholipid syndrome

Espinosa, G., & Cervera, R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902772302 · Cited by 16

The Course of Anticardiolipin Antibody Levels Under Immunoadsorption Therapy

Hauser, A.-C., Hauser, L., Pabinger-Fasching, I., Quehenberger, P., Derfler, K., & Hörl, W. H. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.023 · Cited by 16

The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation

Laurent, P.-A., Garcia, C., Gratacap, M., Vanhaesebroeck, B., Siè, P., Payrastre, B., & Terrisse, A.-D. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0661 · Cited by 16

The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

Favaloro, E. J., & Wong, R. C. W. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0003-7 · Cited by 15

Thrombophilias and Stillbirth

Werner, E. F., & Lockwood, C. J. (2010) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181eb658c · Cited by 15

Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of these guidelines as an educational tool for neurologists. Endorsed by the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the Preventive Cardiovascular Nurses Association

Meschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

Efthymiou, M., Arachchillage, D. J., Lane, P. J., O’Keeffe, A. G., McDonnell, T. C. R., Cohen, H., & Mackie, I. J. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.08.003 · Cited by 15

Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique

Joste, V., Dragon‐Durey, M., & Darnige, L. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.02.006 · Cited by 15

New insights into the molecular basis of the antiphospholipid syndrome

Mineo, C., & Shaul, P. W. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.12.002 · Cited by 15

Thrombophilia and Pregnancy

Hendrix, P. W., Tinelli, A., Malvası, A., & Paidas, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-31377-1_13 · Cited by 15

Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events

Levy, Y. M., Shenkman, B. S., Tamarin, I., Pauzner, R., Shoenfeld, Y., Langevitz, P., Savion, N., & Varon, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21437 · Cited by 15

Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients

Brusch, A. M., Bundell, C. S., & Hollingsworth, P. (2014) · Pathology · doi:10.1097/pat.0000000000000070 · Cited by 14

Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention

Tufano, A., Guida, A., Minno, M. N. D. D., Gregorio, A. M. D., Cerbone, A. M., & Minno, G. D. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.016 · Cited by 14

Evaluation of a new commercial dilute prothrombin time in the diagnosis of Lupus Anticoagulants

Devreese, K. M. J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.04.005 · Cited by 14

Antiphospholipid Syndrome Review

Eby, C. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.06.001 · Cited by 14

Laboratory Testing in Pediatric Rheumatology

Mehta, J. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.03.008 · Cited by 14

Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey

Favaloro, E. J., & Wong, R. C. W. (2009) · Pathology · doi:10.3109/00313020903257731 · Cited by 14

Contraception and Thrombophilia - A statement from the German Society for Gynecological Endo- crinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.)

Rabe, T., Luxembourg, B., Ludwig, M. Z., Dinger, J. C., Bauersachs, R. M., Rott, H., Ao, M., & Albring, C. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 14

Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia

Sniecinski, R. M., Hursting, M. J., Paidas, M. J., & Levy, J. H. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181ff0f7f · Cited by 13

Late mesenteric ischemia after Sars-Cov-2 infection: case report

de Macedo, V. S. O., Moreira, G. B., de Albuquerque, A. C. F., Oliveira, S. C. D. S., Esmeraldo, M. A., & Barbosa, F. C. B. (2021) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.200105 · Cited by 13

Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy

Brochado, M. J. F., Figueiredo, J. F. C., Mendes‐Junior, C. T., Louzada‐Júnior, P., Kim, O. M., & Roselino, A. M. F. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1032-9 · Cited by 13

Biological and Clinical Relevance of Anti‐Prothrombin Antibodies

Ghirardello, A., Bizzaro, N., Zampieri, S., Iaccarino, L., Bassi, N., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E., & Doria, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.056 · Cited by 13

Bilateral sudden hearing loss following habitual abortion: a case report and review of literature.

Yin, T., Huang, F., Ren, J., Liu, W., Chen, X., Li, L., Xie, D., & Lu, Y. (2013) · Europe PMC (PubMed Central) · Cited by 13

A functional coagulation test to identify anti-β2-glycoprotein I dependent lupus anticoagulants

Devreese, K. M. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.06.003 · Cited by 13

Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome

Shovman, O., Gilburd, B., Barzilai, O., Langevitz, P., & Shoenfeld, Y. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-0001-3 · Cited by 13

Pathogenetic Potential of Antiphospholipid Antibodies

Vlachoyiannopoulos, P. G., & Samarkos, M. (2006) · Future Cardiology · doi:10.2217/14796678.2.3.303 · Cited by 13

A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation

Kremers, R., Wahl, D. G., Zuily, S., Ninivaggi, M., Regnault, V., Musiał, J., de Groot, P. G., Devreese, K. M. J., & de Laat, B. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011938 · Cited by 12

Thrombophilia in patients with chronic venous leg ulcers‐a study on patients with or without post‐thrombotic syndrome

Zutt, M., Krüger, U., Rosenberger, A., Schön, M. P., Neumann, C. R., von Ahsen, N., & Kretschmer, L. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04001.x · Cited by 12

The Diagnosis of the Antiphospholipid Syndrome

Pengo, V., Ruffatti, A., & Iliceto, S. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093564 · Cited by 12

Traitement du syndrome des anticorps antiphospholipides

Saadoun, D., Pietté, J. C., Wahl, D. G., & Costedoat-Chalumeau, N. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.01.007 · Cited by 12

Anti-thrombomodulin antibodies and venous thrombosis

Guermazi, S., Mellouli, F., Trabelsi, S., Béjaoui, M., & Dellagi, K. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200410000-00004 · Cited by 12

The antiphospholipid syndrome

Franchini, M., & Veneri, D. (2005) · Hematology · doi:10.1080/10245330500141309 · Cited by 12

Antiphospholipid Antibodies: Laboratory and Pathogenetic Aspects

Vlachoyiannopoulos, P. G., Samarkos, M., Sikara, M. P., & Tsiligros, P. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360601079549 · Cited by 12

Pathophysiology of antiphospholipid antibodies.

de Groot, P. G., & Derksen, R. H. W. M. (2004) · PubMed · Cited by 12

Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays

Raby, A., Moffat, K. A., & Crowther, M. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-339-8_32 · Cited by 12

Digital gangrene as the initial presentation of systemic lupus erythematosus

Adelowo, O., Olaosebikan, H. B., Ajani, W., & Omosebi, D. T. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-006259 · Cited by 12

Actualités sur les facteurs de risque et la prévention des complications thrombotiques de la grossesse

Chauleur, C., Gris, J., SEFFERT, P., & Mismetti, P. (2012) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2012.02.007 · Cited by 11

The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome

Forastiero, R. R., & Martinuzzo, M. E. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1080121 · Cited by 12

Antiphospholipid Syndrome

Wysokinska, E. M., & Ortel, T. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00020-0 · Cited by 11

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects

Vayá, A., Santaolaria, M., Micó, L., Calvo, J., Oropesa, R., Villa, P., Todolí, J., Simó, M., Corella, D., & Ricart, J. M. (2008) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2008-1117 · Cited by 10

Direct oral anticoagulants versus warfarin in patients with single antibody‐positive anti‐phospholipid syndrome

Liu, A., Rupani, K. V., & Naymagon, L. (2022) · European Journal Of Haematology · doi:10.1111/ejh.13770 · Cited by 10

Anticoagulating patients with high-risk acquired thrombophilias

Skeith, L. (2018) · Hematology · doi:10.1182/asheducation-2018.1.439 · Cited by 10

Diagnostic biologique du syndrome des antiphospholipides

Darnige, L. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.08.014 · Cited by 10

Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study

Bertin, D., Beziane, A., Resseguier, N., Pelissier, M., Morange, P., Mège, J., & Bardin, N. (2019) · Rheumatology · doi:10.1093/rheumatology/kez453 · Cited by 9

Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome

Müller-Calleja, N., Ruf, W., & Lackner, K. J. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2305121 · Cited by 11

Thromboprophylaxie pendant la grossesse et le post-partum

Chauleur, C., Barjat, T. R., & Gris, J. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.003 · Cited by 9

Prevalence of Anticardiolipin Antibodies in Patient Cohorts with Distinct Clinical Manifestations of the Antiphospholipid Syndrome

Damoiseaux, J. G. M. C., Peeters, L. L. H., Hupperts, R., Boreas, A., Cate, H. T., & Tervaert, J. W. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04643.x · Cited by 9

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

Radin, M., Cecchi, I., Foddai, S. G., Rubini, E., Barinotti, A., Ramirez, C., Seaman, A., Roccatello, D., Mähler, M., & Sciascia, S. (2020) · Biomedicines · doi:10.3390/biomedicines8120622 · Cited by 9

Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?

de Moerloose, P., & Reber, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00811.x · Cited by 9

Synergistic Thrombotic Risk of Antibodies Against Phosphatidylserine and Prothrombin and β-2-Glycoprotein I

Kim, H., Kim, J.-E., Hwang, S. M., Lee, H. R., Han, K. S., & Kim, H. K. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613497424 · Cited by 8

The Clinical Performance of a New Chemiluminescent Immunoassay in Measuring Anti-β2 Glycoprotein 1 and Anti-Cardiolipin Antibodies

Zhou, J., Hou, X., Zhang, H., Wang, T., & Cui, L. (2018) · Medical Science Monitor · doi:10.12659/msm.910369 · Cited by 8

Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes

Yap, D. Y. H., Thong, K. M., Yung, P. S., Tang, C. S.-M., Y, B. M., & Chan, T. M. (2019) · Lupus · doi:10.1177/0961203319879990 · Cited by 9

The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies

Neville, C., Rauch, J., Kassis, J., Solymoss, S., Joseph, L., Bélisle, P., Subang, R., Chang, E. R., & Fortin, P. R. (2006) · Rheumatology · doi:10.1093/rheumatology/kel050 · Cited by 8

Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world

Deng, X., & Liu, X. (2011) · Rheumatology International · doi:10.1007/s00296-011-2267-2 · Cited by 8

Laboratory Tests for the Antiphospholipid Syndrome

Pericleous, C., Ripoll, V. M., Giles, I., & Ioannou, Y. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0326-9_17 · Cited by 8

Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods

Gehlen, R., Moesbergen, R. G., Bai, C., de Groot, P. G., Jansen, A. J. G., Meijers, J. C. M., de Laat, B., & Remijn, J. A. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102470 · Cited by 7

Management of the antiphospholipid syndrome

Espinosa, G., & Cervera, R. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0004-6 · Cited by 7

Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome

dos Santos, A. P. R., Vaz, C. D. O., Hounkpe, B. W., Jacintho, B. C., Oliveira, J. D., Mesquita, G. L. T. V., dos Santos, I. P., Annichino‐Bizzacchi, J. M., Appenzeller, S., Mazetto, B. D. M., et al. (2022) · Lupus · doi:10.1177/09612033221101731 · Cited by 7

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice

Mameli, A., Barcellona, D., Vannini, M. L., & Marongiu, F. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.111 · Cited by 7

Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.

Cojocaru, I. M., Cojocaru, M., Tănăsescu, R., Burcin, C., Mitu, A. C., Iliescu, I., Dumitrescu, L., Pavel, I., & Siloşi, I. (2008) · PubMed · Cited by 7

Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events

Zhang, S., Wu, Z., Li, J., Li, P., Chen, S., Wen, X., Li, L., Zhang, W., Zhao, J., Zhang, F., et al. (2016) · Rheumatology International · doi:10.1007/s00296-016-3594-0 · Cited by 7

Risk factors for ischemic antiphospholipid syndrome: A case-control study

Mayorga, R. M., Barrera‐Vargas, A., Rull‐Gabayet, M., Aguirre-Aguilar, E., Valdez-López, M., Espinosa-Lira, F., Ramos-Ventura, C., Cano-Nigenda, V., Barboza, M. A., Merayo‐Chalico, J., et al. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106492 · Cited by 7

Coagulation Disorders in Pregnancy

Lockwood, C. J., & Silver, R. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4224-2.50043-0 · Cited by 7

The importance of measuring anticardiolipin antibodies

de Groot, P. G., & Derksen, R. H. W. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01689.x · Cited by 6

Antiphospholipid antibodies may be associated with uveitis

Shapira, Y., Ben‐Arie‐Weintrob, Y., Gilburd, B., Reuter, S., Sánchez‐Castañón, M., López‐Hoyos, M., & Agmon‐Levin, N. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120968729 · Cited by 6

Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis

Li, R., Daguzan, M., Vandermijnsbrugge, F., Gyling, M., & Cantinieaux, B. (2014) · Acta Clinica Belgica · doi:10.1179/2295333714y.0000000060 · Cited by 6

Pathogenesis and management of antiphospholipid syndrome

Greaves, M. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70002-7 · Cited by 7

Immunotherapeutic strategies in antiphospholipid syndrome

Hoi, A. Y.-B., Ross, L., Day, J., & Buchanan, R. R. C. (2016) · Internal Medicine Journal · doi:10.1111/imj.13245 · Cited by 7

MicroRNA expression in antiphospholipid syndrome: a systematic review and microRNA target genes analysis.

Suhiman, M. S., Mohamad, M. A., Asnawi, A. W. A., Hayati, A. R., Azma, M. M., Syahrina, A. R. N., Nazefah, A. H., Jameela, S., & Fariha, M. M. N. (2016) · PubMed · Cited by 6

Síndrome antifosfolipídico en el siglo xxi

Ruiz‐Irastorza, G., Martínez-Berriotxoa, A., & Egurbide, M. V. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.10.046 · Cited by 6

Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.

Viveros, M. E., Cabiedes, J., Reyes, E., & Cabral, A. R. (2005) · PubMed · Cited by 6

Thromboembolic Disorders

Pettker, C. M., & Lockwood, C. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00043-0 · Cited by 6

Antiphospholipid Antibodies and Risk for Recurrent Vascular Events

Wahl, D. G., Regnault, V., de Moerloose, P., & Lecompte, T. (2004) · JAMA · doi:10.1001/jama.291.22.2701-a · Cited by 6

Antithrombotic prophylaxis in women with thrombophilia and pregnancy complications

Conard, J. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00833.x · Cited by 6

Phospholipid Autoantibodies (Nonanticardiolipin)-Antiprothrombin Antibodies

Pregnolato, F., & Chighizola, C. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-56378-1.00088-5 · Cited by 5

Antiphospholipid Syndrome

Annem, C., & Furie, R. A. (2017) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000564 · Cited by 5

Pathogenic Mechanisms of Thrombosis in Antiphospholipid Syndrome (APS)

Marina, P., Eleftheria, P., & Panayiotis, G. (2011) · InTech eBooks · doi:10.5772/25522 · Cited by 5

Antiphospholipid Syndrome

Avčin, T., & O’Neil, K. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00024-7 · Cited by 5

Improving management of pregnancy in antiphospholipid antibody-positive women.

Galli, M. (2006) · PubMed · Cited by 5

Syndrome des antiphospholipides et grossesse

Arnaud, L., Mathian, A., Huong, D. U. L. T., Costedoat-Chalumeau, N., & Amoura, Z. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2011.02.012 · Cited by 4

Anti-Prothrombin Antibodies

Galli, M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50008-5 · Cited by 4

Role of Platelet‐Bound C4d ( PC4d ) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus

Gartshteyn, Y., Conklin, J., Petri, M., Kyttaris, V. C., GOLDMAN, D. W., Kammesheidt, A., Askanase, A., & Alexander, R. V. (2023) · Arthritis Care & Research · doi:10.1002/acr.25107 · Cited by 4

Phospholipid inhibitors

Galli, M. (2011) · Hämostaseologie · doi:10.5482/ha-1165 · Cited by 4

Perioperative bridging therapy with low molecular weight heparin for patients with inherited thrombophilia and antiphospholipid syndrome on long-term acenokumarol therapy

Wiszniewski, A., Szopiński, P., Ratajczak, J., Bilski, R., & Bykowska, K. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328340e690 · Cited by 4

The Pathophysiology of Antiphospholipid Syndrome

Sada, P. R., Cohen, H., & Isenberg, D. A. (2015) · The Open Urology & Nephrology Journal · doi:10.2174/1874303x01508010002 · Cited by 4

Pathophysiological insights into the antiphospholipid syndrome

Manukyan, D., Müller‐Calleja, N., & Lackner, K. J. (2016) · Hämostaseologie · doi:10.5482/hamo-16-07-0020 · Cited by 4

Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?

Devreese, K. M. J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.01.002 · Cited by 4

Polimorfismo Val247Leu do gene β2-glicoproteína 1 pode justificar a gênese de anticorpos antiβ2GP1 e síndrome do anticorpo antifosfolípide na hanseníase multibacilar

Brochado, M. J. F., do Nascimento, M. M. P., Louzada‐Júnior, P., Figueiredo, J. F. C., & Roselino, A. M. F. (2009) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962009000400006 · Cited by 4

The current standards for laboratory diagnosis of rheumatic diseases and their use in real clinical practice

Александрова, Е. Н., Novikov, A. A., & Nasonov, E. L. (2013) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2013-1246 · Cited by 4

[Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].

Hong, L. R., Chen, Y. J., Jiang, Q., Jia, R. L., Li, C., & Feng, L. H. (2023) · PubMed Central · doi:10.19723/j.issn.1671-167x.2023.06.012 · Cited by 3

Acquired Coagulation Disorders Caused by Inhibitors

Kruse‐Jarres, R., & Leissinger, C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00006-3 · Cited by 3

Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT

Fu, H., Zhao, J., Xu, L., Liu, K., Wang, Y., Chen, H., Han, W., Wang, J., Wang, F., Huang, X., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-018-9493-8 · Cited by 3

Reproductive Immunology and Its Disorders

Barrier, B. F., Gargiulo, A., & Schust, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00013-9 · Cited by 3

Thromboembolism risk following recurrent miscarriage

Martínez‐Zamora, M. Á., Cervera, R., & Balasch, J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.839201 · Cited by 3

Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies

Tabata, R., Tabata, C., & Kita, Y. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0763-1 · Cited by 3

The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome

Alba, P. B., Bertolaccini, M. L., & Khamashta, M. A. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.613 · Cited by 3

Antiphospholipid Syndrome

Rand, J. H., & Wolgast, L. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00020-8 · Cited by 3

ANTIPHOSPHOLIPID SYNDROME

Avčin, T., & O’Neil, K. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10022-6 · Cited by 3

Antiphospholipid antibodies and thrombosis: strength of association

Galli, M., & Barbui, T. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200206 · Cited by 61

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170

Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice

Galli, M. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083810 · Cited by 23

Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome

Yatish, N. S. (2001) · Frontiers in bioscience · doi:10.2741/setty · Cited by 8

Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome

de Groot, P. G., & de Laat, B. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.008 · Cited by 62